7-year-old Maverick has a rare genetic disorder that severely limits his vision. Now, a medication called Luxturna – the first gene therapy approved by the FDA – has the potential to substantially improve his sight, via an injection of a gene-carrying virus underneath his retina.

Floating Vimeo Video